Leading Pharmaceutical Manufacturer Avoids $42 Million Exposure
Facility Background / Challenge
A global pharmaceutical company manufactures one of their blockbuster vaccines in a 365,000 sf New York facility. This aged and leaky facility posed a severe threat to the sold-out capacity which if shut down would cost them over $42 million dollars in production losses, clean-up costs, business interruption, fines, and lost market share. One of their options included shutting down the facility and relocating the production to an off-shore site. RAM USA was hired to develop objective options.
RAM USA's solution roadmap started with aerial and hand-held infrared thermography to identify and quantify the extent of the hidden moisture damage. This data complemented the physical roof and wall surveys to achieve a comprehensive list of prioritize recommendations and budgets. The best option was to preserve the building and implement an aggressive restoration / replacement program.
Our design and engineering teams developed detailed specifications that helped bring the project in under budget estimates due to "apples-to-apples" bids. The projects were made more complex due to the winter install, elevated roof work, and very tight staging parameters. RAM's project management and quality control teams covered multiple, simultaneous reroofing and wall restoration projects requiring three full-time supervisors on the roof and inside the plant.
One Phone Call to Make
The successful install was done on time and under budget. The Client only wanted "One Phone Call to Make" or one company to take full responsibility. RAM's collaborative approach included Design/Build services and our 15-year warranty and maintenance inspection program.
Back to Project Profiles / Case Studies →